Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Epidemics. 2017 Mar;18:81–91. doi: 10.1016/j.epidem.2017.02.004

Table 3.

Average (95% confidence interval) simulated T. cruzi seroprevalence (%) for each time period using the Princeton Model compared to historical Venezuelan data.

Time Periods (Years)

1980–1989 1990–1998
Historical Dataa
Ages 0–9 years 1.1 (0.9–1.2) 0.5 (0.42–0.56)
Ages 10–19 years 2.4 (2.2–2.6) 1.8 (1.6–2.0)
Ages 20–29 years 12.4 (11.5–12.8) 5.9 (5.5–6.3)
Ages 30–19 years 26.6 (25.5–27.6) 16.1 (15.4–16.8)
Ages 40–49 years 37.5 (36.2–38.8) 28.3 (27.2–29.4)
Ages 50 years and older 48.0 (47.0–48.9) 43.0 (42.1–43.9)
Targeting the Last Time Point
Ages 0–9 years 0.73 (0.71–0.75)
Ages 10–19 years 1.90 (1.88–1.93)
Ages 20–29 years 7.18 (6.99–7.37)
Ages 30–19 years 18.41 (18.02–18.81)
Ages 40–49 years 30.39 (30.01–30.78)
Ages 50 years and older 45.23 (45.07–45.39)
Targeting the Last Two Time Points
Ages 0–9 years 2.93 (2.88–2.98) 1.30 (1.27–1.33)
Ages 10–19 years 6.84 (6.72–6.96) 3.63 (3.58–3.69)
Ages 20–29 years 16.81 (16.37–17.25) 8.09 (7.98–8.20)
Ages 30–19 years 27.76 (27.30–28.21) 14.61 (14.39–14.82)
Ages 40–49 years 41.98 (41.56–42.40) 24.90 (24.53–25.27)
Ages 50 years and older 43.01 (42.95–43.07) 39.82 (39.64–40.01)
a

Values are average (95% confidence interval) as reported in Ache and Matos (Ache and Matos, 2001).